MagnetisMM-20
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
Arms / Cohorts
Experimental:Part 2A: Elranatamab and Maplirpacept
Accepting patients
Experimental: Dose Escalation:Part 1: Elranatamab, Carfilzomib and Dexamethasone
Accepting patients
Experimental, Dose Randomization:Part 2B: Elranatamab and Maplirpacept
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.